Skip to main contentSkip to navigation
Sirius Investors
Sesen Bio, Inc.

Sesen Bio, Inc.

SESN
NASDAQHealthcare

Sesen Bio, Inc. (SESN) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Sesen Bio, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2024
P/E Ratio
-0.43
Burn Risk
P/B Ratio
-0.93
Equity Deficit
Earnings Yield
-2.32%
Yield Gap

Profitability Health

2024
Return on Equity
216.69%
Strong
WeakModerateStrong
Operating Margin
-
No data
Net Profit Margin
-
No data

Growth Indicators

2024
Revenue Growth
-
No data
Net Income Growth
-
No data
EPS Growth
-
No data

Efficiency & Liquidity

2024
Current Ratio
1.48
Moderate
WeakModerateStrong
Quick Ratio
1.48
Moderate
WeakModerateStrong
Asset Turnover
-
No data
Inventory Turnover
-
No data

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2024
Free Cash Flow Yield
-2.30%
Weak
WeakModerateStrong
EV / Free Cash Flow
-0.18x
Strong
WeakModerateStrong
Net Debt / EBITDA
-4.60x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
-
No data
Return on Invested Capital
-
No data
Cash Conversion Cycle
0.00 days
Strong
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for SESN.

View Financial Statements